References
- Taïeb A, Picardo M. Epidemiology, definitions and classification. In: Picardo M, Taïeb A, editors. Vitiligo. Berlin: Springer-Verlag; 2010. p.13–24.
- Nordlund J, Majumder P. Recent investigations on vitiligo vulgaris: advances in clinical research. Dermatol Clin. 1997; 15: 69–78.
- Schallreuter KU, Wood JM, Ziegler I, Lemke KR, Pittelkow MR, Lindsey NJ, Gütlich M. Defective tetrahydrobiopterin and catecholamine biosyntheis in the depigmentation disorder Vitiligo. Biochim Biophys Acta.1994;1226:181–192.
- Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol. 1997;109:310–313.
- Khan R, Satyam A, Gupta S, et al. Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Archives of Dermatological Res. 2009;301:731–737.
- Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone A. Comparison between 308- nm monochromatic excimer light and narrowband UVB phototherapy (311–313 nm) in the treatment of vitiligo – a multicentre controlled study. J Euro Acad Dermatol Venerol. 2007;21:956–963.
- Al-Mutairi N, Manchanda Y, Al-Doukhi A, Al-Haddad A. Long term results of split-skin grafting in combination with excimer laser for stable vitiligo. Dermatol Surg. 2010;36: 499–505.
- Novak Z, Berces A, Ronto G, Pállinger E, Dobozy A, Kemény L. Efficacy of different UV-emitting light sources in the induction of T-cell apoptosis. Photochem Photobiol. 2004;79:434–439.
- Leone G, Iacovelli P, Paro Vidolin A, Picardo M. Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study. J Eur Acad Dermatol Venereol. 2003; 17:531–537.
- Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J. Dermatol. 1999;26:653–657.
- Shameer P, Prasad PV, Kaviarasan PK. Serum zinc level in vitiligo: a case control study. Indian J Dermatol Venereol Leprol. 2005;71:206–207.
- Taieb A, Alomar A, Bohm M, Dell'anna ML, De Pase A, Eleftheriadou V, et al. Gidelines for the management of vitiligo. British J of dermatology. 2013;168:5–19
- Xiang L. Once-weekly treatment of vitiligo with monochromatic excimer light 308 nm in Chinese patients. J Eur Acad Dermatol Venereol. 2008;22:899–900.
- Dell’Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, et al. Antioxidants and narrow band- UVB in the treatment of vitiligo: A double-blind placebo controlled trial. Clin Exp Dermatol. 2007;32:631–636.
- Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol. 2009;49:852–855.
- Kostovic K, Pastar Z, Pasic A, Ceović R. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase. Acta Dermatol Venereol Croat. 2007;15:10–14.
- Taneja A, Trehan M, Taylor C. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol. 2003;42: 658–662.
- Ostovari N, Passeron T, Zakaria W, Fontas E, Larouy JC, Blot JF, et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Lasers Surg Med. 2004;35:152–156.
- Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. The efficacy of excimer laser (308 nm) for vitiligo at different body sites. J Eur Acad Dermatol Venereol. 2006;20: 558–564.
- Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol. 2006;29:133–137.